期刊文献+

鬼臼毒素固体脂质纳米粒冻干粉的制备及理化性质考察 被引量:5

Preparation and physicochemical characteristics of podophyllotoxin loaded solid lipid nanoparticles
下载PDF
导出
摘要 目的:制备含有不同冻干保护剂的鬼臼毒素固体脂质纳米粒(POD-SLN)冻干粉,并考察其理化性质,筛选出最佳配方。方法:实验于2006-12/2007-11在南方医科大学药学部实验室完成。冻干配方为15%海藻糖、15%甘露醇和二者联用各取5%,冷冻干燥制作冻干粉制剂。扫描电镜下观察冻干粉复溶后粒子形态,Image-ProPlus6.0软件计算粒径大小,高效液相考察固体脂质纳米粒的药物包封率,并考察冻干粉的外观、复溶和4℃保存对其影响,评价不同辅料对冻干品的影响。结果:①外观和复溶情况:海藻糖冻干粉、海藻糖联用甘露醇冻干粉表面均松脆多孔,疏松,复溶较快,约需20s,甘露醇冻干粉表面较光滑,结构致密,饼状,复溶较慢,需借助外力。冻干粉样品4℃冰箱放置24h、1,3,6个月其外观和复溶均无明显变化。②电镜下粒子形态:呈圆形或椭圆形,分布较均匀,冻干前后无明显差异。③粒径:未加冻干保护剂时为(82.65±18.43)nm,加入海藻糖、海藻糖联用甘露醇、甘露醇后分别为(94.78±21.94),(109.26±16.15),(114.63±21.42)nm。④包封率:未加冻干保护剂时为87.4%,加入海藻糖、海藻糖联用甘露醇、甘露醇后分别为86.2%,80.3%,79.6%。结论:以15%海藻糖为冻干保护剂制备的鬼臼毒素固体脂质纳米粒冻干粉粒径较小,包封率高,稳定性好,其制备工艺合理可行。 AIM: To prepare podophyllotoxin-loaded solid lipid nanoparticles (POD-SLN) powder containing different cryoprotectors, and study its physicochemical characteristics for searching the optimal prescription. METHODS: The experiment was carded out in the laboratory, Department of Pharmacy, Nanfang Hospital of Southern Medical University from December 2006 to November 2007. Cryopreservation prescription consisted of 15% trehalose, 15% Mannitol and combination of the two ones (each 5%) as cryoprotectors to prepare POD-SLN powder. Transmission electron microscope, Image-Pro Plus 6.0 software, and high-performance of liquid chromatography were used to detect the particle diameter and entrapment efficiency, respectively. Powder appearance and dissolution, as well as the stability when stored at 4 ℃ were all investigated to evaluate the effect of different adjuvant on the powder. RESULTS: ①Appearance and dissolution: The surface of POD-SLN powder contained 15% Trehalose or combination of 5% Trehalose and 5% Mannitol looked slake and porous, and the two kinds of POD-SLN powder dissolved in water rapidly, about 20 seconds. The surface of POD-SLN powder contained 15% Mannitol was smooth, dense, cake-shaped, and hard to dissolve. Ultrasonic oscillation could be conducted with assistance of external force. When stored at 4℃ for 24 hours, l month, 3 months and 6 months, the powder samples showed no significant differences of appearance and dissolution.②The particles of POD-SLN powder was round or ellipse, with even distributions. There was no significant difference before and after cryopreservafion.③The particle diameter of POD-SLN powder without cryoprotectors and with Trehalose, Mannitol or combination of the two were (82.65± 1.8.43) nm, (94.78±21.94) rim, (114.63 ±21.42) nm, (109.26±16.15) nm separately. ④ The entrapment efficiency of POD-SLN powder with cryoprotectors and with Trehalose, Mannitol or combination of the two were 87.4%, 86.2%, 79.6%, 80.3% separately. CONCLUSION: The small particle diameter, high entrapment efficiency and good stability of POD-SLN powder contained 15% Trehalose are satisfying, and the preparation process is practical.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2008年第10期1835-1838,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
基金 广东省科技计划项目(2007B031003006)~~
  • 相关文献

参考文献19

  • 1Kinghorn GR, McMillan A, Mulcahy F, et al. An open comparative study of the efficacy of 0.5% podophyllotoxin lotion and 25% podophyllotoxin solution in the treatment of condylomata acuminata in males and females. Int J STD AIDS 1993;4(4): 194-199
  • 2王莉莉,周应军.抗癌物质鬼臼毒素及其衍生物研究进展[J].国外医药(植物药分册),2006,21(1):6-9. 被引量:19
  • 3张敏,曾抗,李国锋,史毓杰,周红玲.鬼臼毒素-固体脂质纳米粒的制备及质量考察[J].中国组织工程研究与临床康复,2007,11(18):3555-3558. 被引量:10
  • 4Muller RH, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art. Eur J Pharm Biopharm 2000;50(1): 161-177
  • 5Sch?fer-Korting M, Mehnert W, Korting HC. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev 2007; 59(6): 427-43
  • 6张敏,曾抗,李国锋,史毓杰,杨西晓,江中洪.鬼臼毒素-固体脂质纳米粒的皮肤毒理学实验[J].中国组织工程研究与临床康复,2007,11(13):2420-2424. 被引量:14
  • 7Liu J, Gong T, Wang C,et al. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: Preparation and characterization. Int J Pharm 2007;340(1-2) : 153-162
  • 8Tiyaboonchai W, Tungpradit W, Plianbangchang P. Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. Int J Pharm. 2007; 337(1-2): 299-306
  • 9Hancock BC, Zografi G. Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci 1997; 86(1): 1-12
  • 10李保国,周伟伟.生物药品冷冻干燥研究[J].干燥技术与设备,2005,3(4):179-183. 被引量:11

二级参考文献69

共引文献68

同被引文献52

  • 1侯冬枝,谢长生.米非司酮固体脂质纳米粒冷冻干燥性能的研究[J].中国药科大学学报,2004,35(5):413-416. 被引量:7
  • 2陈永法,龚明涛,张钧寿,高忠明,王猛.紫杉醇冻干纳米乳的制备及理化性质[J].中国天然药物,2005,3(4):235-237. 被引量:14
  • 3刘启德,梁美蓉,欧卫平,叶少梅,冯美蓉,王宁生.青藤碱时辰药代动力学研究[J].中药新药与临床药理,1995,6(1):23-26. 被引量:29
  • 4张乐乐,奉建芳,陈满仓,祝林.羟基喜树碱长循环脂质体冻干剂的制备及理化性质[J].中国医药工业杂志,2007,38(3):245-248. 被引量:8
  • 5Friedman ES,Friedman PM,Cohen DE,et al.Aller-gic contact dermatitis to topical minoxidil solution:eti-ology and treatment[J].Am Acad Dermatol,2002,46:309-312.
  • 6Mura S,Pirot F.Liposomes and niosomes as potentialcarriers for dermal delivery of minoxidil[J].Drug Tar-get,2007,15(2):101-108.
  • 7Hasanovic A,Hollick C,Fischinger K,et al.Im-provement in physicochemical parameters of DPPC lipo-somes and increase in skin permeation of aciclovir andminoxidil by the addition of cationic polymers[J].Eur JPharm Biopharm,2010,75(2):148-153.
  • 8Jain B,Singh B,Katare OP,et al.Development andcharacterization of minoxidil-loaded liposomal systemfor delivery to pilosebaceous units[J].J Liposome Res,2010,20(2):105-114.
  • 9Radtken,Miiller RH NLCTM.Nanostructured lipidCarriers the new gene ration of lipid drug carrier[J].New Drugs,2001,2:48-52.
  • 10Müller RH,Petersen RD,Hommoss A,et al.Nano-structured lipid carriers(NLC)in cosmetic dermal prod-ucts[J].Adv Drug Deliv Rev,2007,59(6):522-530.

引证文献5

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部